Sugi Predict

Sugi Predict / Compounds / SCHEMBL9723894

SCHEMBL9723894

SCHEMBL9723894

[CH2]C(c1ccccc1)([N+](=O)[O-])[N+](=O)[O-]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.42
▸ LMNA P02545 1/20 0.42
▸ FBP1 P09467 4/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ TSHR P16473 3/20 0.35
▸ KCNN4 O15554 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ CRHBP P24387 2/20 0.33
▸ CRHR2 Q13324 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ TLR9 Q9NR96 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ CES2 O00748 1/20 0.32
▸ CES1 P23141 1/20 0.32
▸ PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27936749 0.81 ALDH1A1 (0.42) ALDH1A1LMNAFBP1CYP19A1TSHR
SCHEMBL27952347 0.77 CYP1A2 (0.40) ALDH1A1LMNAFBP1CYP19A1TSHR
SCHEMBL8367325 0.76 CES1 (0.44) ALDH1A1TSHRMEN1KMT2ACYP1A2
SCHEMBL28383675 0.75 ALDH1A1 (0.46) ALDH1A1LMNAFBP1CYP19A1TSHR
SCHEMBL1194233 0.75 ALDH1A1 (0.46) ALDH1A1LMNAFBP1CYP19A1TSHR
SCHEMBL114442 0.75 ALDH1A1 (0.46) ALDH1A1LMNAFBP1CYP19A1TSHR
SCHEMBL1167741 0.73 ALDH1A1 (0.44) ALDH1A1LMNAFBP1CYP19A1TSHR
SCHEMBL10495598 0.73 ALDH1A1 (0.48) ALDH1A1LMNAFBP1CYP19A1TSHR
SCHEMBL2056618 0.73 KCNN4 (0.48) ALDH1A1LMNAFBP1CYP19A1TSHR
SCHEMBL3037176 0.73 ALDH1A1 (0.44) ALDH1A1LMNAFBP1CYP19A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5079373-A AMINO ACIDS PROTECTED WITH 6-SULFONYL CHROMANS WENDSTONE CHEMICALS PLC (GB) 1992-01-07 — — US claimed
EP-0293073-B1 CHROMAN-6-SULPHONYL DERIVATIVES Wendstone Chemicals P.L.C. (GB) 1991-09-18 — — EP claimed
EP-0293073-A1 Chroman-6-sulphonyl derivatives Wendstone Chemicals P.L.C. (GB) 1988-11-30 — — EP claimed
CN-113896607-B Olefin oligomerization process using a catalyst comprising a chromium complex having a phosphacycle-containing ligand 陶氏环球技术有限责任公司 2024-04-16 — — CN disclosed
US-11896965-B2 Chromium complex and catalyst therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2024-02-13 — — US disclosed
US-20230112954-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2023-04-13 — — US disclosed
US-11623209-B2 Process for oligomerization DOW GLOBAL TECHNOLOGIES LLC (US) 2023-04-11 — — US disclosed
US-20220176363-A1 PROCESS FOR OLIGOMERIZATION DOW GLOBAL TECHNOLOGIES LLC (US) 2022-06-09 — — US disclosed
US-11260381-B2 Process for oligomerization DOW GLOBAL TECHNOLOGIES LLC (US) 2022-03-01 — — US disclosed
CN-107548385-B Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand 陶氏环球技术有限责任公司 2022-01-21 — — CN disclosed
CN-113896607-A Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand 陶氏环球技术有限责任公司 2022-01-07 — — CN disclosed
CN-107567355-A The part containing phosphorus ring and olefin oligomerization catalyst therefrom for chromium complex 陶氏环球技术有限责任公司 2018-01-09 — — CN disclosed
CN-107548385-A Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand 陶氏环球技术有限责任公司 2018-01-05 — — CN disclosed
US-8673885-B1 Compounds for the protection of sulfur containing linkers in nucleic acid synthesis DUFF ROBERT (US) 2014-03-18 — — US disclosed
US-5164515-A Chemical compounds WENDSTONE CHEMICALS PLC (GB) 1992-11-17 — — US disclosed
US-5079373-A AMINO ACIDS PROTECTED WITH 6-SULFONYL CHROMANS WENDSTONE CHEMICALS PLC (GB) 1992-01-07 — — US disclosed
EP-0293073-B1 CHROMAN-6-SULPHONYL DERIVATIVES Wendstone Chemicals P.L.C. (GB) 1991-09-18 — — EP disclosed
US-4946971-A 6-sulfonyl chromans WENDSTONE CHEMICALS PLC (GB) 1990-08-07 — — US disclosed
EP-0293073-A1 Chroman-6-sulphonyl derivatives Wendstone Chemicals P.L.C. (GB) 1988-11-30 — — EP disclosed
EP-0239354-A2 2,2-Dinitrophenylethane derivatives and their application as protecting compounds Wendstone Chemicals P.L.C. (GB) 1987-09-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230112954-A1 CHROMIUM COMPLEX AND CATALYST THEREFROM OXER1, LIG1, PICALM ALDH1A1 4013/4885LMNA 3103/4885FBP1 582/4885
US-11260381-B2 Process for oligomerization OXER1, NOD1, LIG1 ALDH1A1 4182/4885LMNA 3488/4885FBP1 252/4885
US-11623209-B2 Process for oligomerization OXER1, NOD1, LIG1 ALDH1A1 4182/4885LMNA 3488/4885FBP1 252/4885
US-11896965-B2 Chromium complex and catalyst therefrom OXER1, LIG1, PICALM ALDH1A1 4013/4885LMNA 3103/4885FBP1 582/4885
US-20220176363-A1 PROCESS FOR OLIGOMERIZATION OXER1, NOD1, LIG1 ALDH1A1 4182/4885LMNA 3488/4885FBP1 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.